Loading clinical trials...
Loading clinical trials...
Gefitinib Alone or With Concomitant Whole Brain Radiotherapy for Patients Harboring an EGFR Mutation With Multiple Brain Metastases From Non-Small-cell Lung Cancer: a Phase II/III Randomized Controlled Trial
Conditions
Interventions
Gefitinib
WBRT
Locations
1
China
Varian linear accelerato
Shanghai, Shanghai Municipality, China
Start Date
November 1, 2014
Primary Completion Date
November 1, 2017
Completion Date
November 1, 2017
Last Updated
January 26, 2015
NCT05692635
NCT06305754
NCT07190248
NCT07100080
NCT07195695
NCT06357533
Lead Sponsor
Shanghai Chest Hospital
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions